Skip to main content
Caplight Logo









Beijing Daxiang Biotech Co., Ltd.

Beijing Daxiang Biotech Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://daxiangbio.com/

Last Round

Series B

Feb 13, 2026

Total Funding Raised

$42.27M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Beijing Daxiang Biotech Co., Ltd. is a biotechnology company that develops organ-on-a-chip and organoid technologies for drug discovery, disease modeling, and precision medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

organ-on-a-chiporganoidmicrofluidicsdrug discoveryin vitro modelsbiomimetic systemstransmembrane resistanceTEERtoxicity testingprecision medicinelab-on-a-chipdrug screening3D cell culturecontract researchCRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beijing Daxiang Biotech Co., Ltd. Comparables

Compare Beijing Daxiang Biotech Co., Ltd. with similar companies based on industry and business-model similarity.

Beijing Daxiang Biotech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Jiangsu Avatarget Biotechnology Co., Ltd.
91%
D1 Medical Technology
89%
Anhui Luohua Biotechnology Co., Ltd.
89%

Beijing Daxiang Biotech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 13, 2026
Pre SeedNov 14, 2022
Series A ExtensionJul 30, 2021
Series AMay 11, 2021
AngelSep 12, 2020
Seed
Aug 1, 2019

Beijing Daxiang Biotech Co., Ltd. Investors

Notable investors and investment history

Beijing Daxiang Biotech Co., Ltd. investors
InvestorRounds
Qiandao FundPre Seed
MiraclePlusSeed, Series A
CDH VGCSeries A Extension, Series A
Proxima Ventures Ltd.Pre Seed
Jiuyo Capital ManagementAngel, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 13, 2026

    $14.5M round completed.

  • Apr 9, 2025

    Monthly visitors grew 128% MoM, reaching 162.

Beijing Daxiang Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beijing Daxiang Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beijing Daxiang Biotech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range4
Year Founded2018
Last FundingFeb 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?